Reagents and supplies required for molecular patient care testing

Ended Purchase Order Awarded

Contract number
75N90021P00196
Awardee
Awarding agency
Obligated
$75,025

Award facts

Contract value 100% obligated
$75,025.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27712, USA

Award details come from SAM.gov/FPDS.

About this award

This is a $75,025.40 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics and laboratory testing solutions. The contract is for the supply of reagents and supplies required for molecular patient care testing, with a period of performance ending on February 8, 2022. The contract does not have a set-aside designation. Biomerieux Inc. is the prime contractor, and there is no information provided about any subcontractors. The NIH Clinical Center, part of the U.S. Department of Health and Human Services, is the funding agency for this contract, which is likely to support its clinical laboratory operations and patient care activities.

Quick answers

Who was awarded contract 75N90021P00196?

75N90021P00196 was awarded to Biomerieux Inc. by NIH Clinical Center (National Institutes of Health) on February 9, 2021.

How much is contract 75N90021P00196 worth?

The government has obligated $75,025 on 75N90021P00196.

Was contract 75N90021P00196 competed?

The extent of competition for 75N90021P00196 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award